Entera Bio Ltd expected to post a loss of 13 cents a share - Earnings Preview

Entera Bio

07/11/2022 11:53

* Entera Bio Ltd  ENTX.OQ   ENTX.O  is expected to show a
fall in
quarterly revenue when it reports  results on November 9
(estimated). 
    * The Jerusalem Israel-based   company is expected to report
 a
50.0% decrease in revenue to $70 thousand from $140 thousand a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Entera Bio Ltd is
for a
loss of 13 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Entera Bio
Ltd is
$7.5​, above​ its last closing price of $0.65. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.14       -0.16      -0.11     Beat    31.3
 Mar. 31 2022  -0.18       -0.18      -0.13     Beat    26.4
 Dec. 31 2021  -0.31       -0.23      -0.21     Beat    10​
 Sep. 30 2021  -0.13       -0.11      -0.09     Beat    21.7
 ​​Jun.        -0.12       -0.12      -0.21     Missed  -75
 30 2021                                                
 Mar. 31 2021  -0.12       -0.12      -0.11     Beat    8.3​
 Dec. 31 2020  -0.14       -0.14      -0.13     Beat    7.1
 Sep. 30 2020  -0.20       -0.20      -0.09     Beat    55
 This summary was machine generated November 7 at 11:53 GMT.  All
figures in US dollars  unless otherwise stated